Tokyo, Japan, Oct 27, 2006 - (JCN Newswire) - Stelic Institute & Co., a Tokyo-based bioventure company specializing in regenerative medicine, has announced development of a new treatment method for acute
liver failure.
The most common causes of acute
liver failure are drug toxicity, as seen with acetaminophen intoxication and viral hepatitis.
At present no effective direct treatment for
liver failure is available, and patients must receive a liver transplant or endure prolonged hospitalization with a significant mortality rate.
Fiona "We I was suffering from
liver failure. Had it not been for Ward 17 staff I would have died Fiona Whitehead
The hospital also received two alcoholic hepatitis cases this year, which lead to
liver failure. "Usually the patients just come with abdominal pain and nausea and only by chance we find the hepatitis marker is high."
An autopsy gave the cause of death as acute
liver failure due to alcoholic liver disease with cumulative paracetamol use as a possible contributory factor.
In our country, hepatitis B virus (HBV) infection is the main cause of acute-on-chronic
liver failure (ACLF) [3], the mortality of which is as high as 62.18%-72.3% [4-6].
Meanwhile, AFP is considered a biomarker of proliferating liver stem cells in liver injury conditions as well, and the recruitment of liver progenitor cells is associated with a better outcome for
liver failure [12,13].
Acute
liver failure can result from acetaminophen overdose, viral infection, toxins, and other disease conditions [1-3].
Acute
liver failure (ALF) is a complex and rare clinical syndrome characterized by the development of severe liver dysfunction, promoted by extensive death of functional cells.
The inquest into his death, at Teesside Coroner's Court, heard that Mr Pearson suffered from a number of conditions including epilepsy and diabetes but had died as a result of end-stage
liver failure.
Keywords: Duloxetine toxicity,
Liver failure, Serotonin syndrome.